M. Dror Michaelson
- Cancer Research top 0.1%
- Cancer Genomics and Diagnostics 53
- Pulmonary and Respiratory Medicine top 0.05%
- Renal cell carcinoma treatment 134
- Prostate Cancer Treatment and Research 38
- Oncology top 0.2%
- Pancreatic and Hepatic Oncology Research 22
- Molecular Biology top 0.5%
- Renal and related cancers 54
- Nephrology top 2%
-
- Bladder and Urothelial Cancer Treatments 28
-
- Economic and Financial Impacts of Cancer 25
-
- Radiopharmaceutical Chemistry and Applications 19
- Co-authors
- Robert J. MotzerThomas E. HutsonRonald M. BukowskiSindy T. KimRobert A. FiglinCharles M. BaumPiotr TomczakSylvie Négrier
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
M. Dror Michaelson
209 papers receiving 16.8k citations
Hit Papers
Peers
Comparison fields: 5 of 130
- Cancer Research 6.0k
- Pulmonary and Respiratory Medicine 12.3k
- Oncology 6.1k
- Molecular Biology 9.4k
- Nephrology 369
Countries citing papers authored by M. Dror Michaelson
This map shows the geographic impact of M. Dror Michaelson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Dror Michaelson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Dror Michaelson more than expected).
Fields of papers citing papers by M. Dror Michaelson
This network shows the impact of papers produced by M. Dror Michaelson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Dror Michaelson. The network helps show where M. Dror Michaelson may publish in the future.
Co-authorship network
The 25 scholars most cited alongside M. Dror Michaelson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 51 | |
| 2 | 2023 | 9 | |
| 3 | 2019 | 15 | |
| 4 | 2018 | 26 | |
| 5 | Cabozantinib Versus Sunitinib As Initial Targeted Therapy for Patients With Metastatic Renal Cell Carcinoma of Poor or Intermediate Risk: The Alliance A031203 CABOSUN Trialbreakdown → | 2017 | 507 |
| 6 | 2017 | 12 | |
| 7 | Lenvatinib, everolimus, and the combination in patients with metastatic renal cell carcinoma: a randomised, phase 2, open-label, multicentre trialbreakdown → | 2015 | 688 |
| 8 | 2011 | 24 | |
| 9 | 2010 | 108 | |
| 10 | Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinomabreakdown → | 2009 | 1711 |
| 11 | 2009 | 123 | |
| 12 | 2008 | 321 | |
| 13 | Comparative efficacy of sunitinib administered on an intermittent or a continuous daily dosing schedule in metastatic renal cell carcinoma (mRCC) and gastrointestinal stromal tumor (GIST) patients predicted using population PK approaches | 2008 | 4 |
| 14 | 2007 | 235 | |
| 15 | 2007 | 5 | |
| 16 | Activity of SU11248, a Multitargeted Inhibitor of Vascular Endothelial Growth Factor Receptor and Platelet-Derived Growth Factor Receptor, in Patients With Metastatic Renal Cell Carcinomabreakdown → | 2005 | 1304 |
| 17 | 2005 | 154 | |
| 18 | 1997 | 65 | |
| 19 | 1997 | 56 | |
| 20 | 1996 | 62 |
About M. Dror Michaelson
M. Dror Michaelson is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Oncology, having authored 215 papers that have together received 17.1k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (134 papers), Renal and related cancers (54 papers), Cancer Genomics and Diagnostics (53 papers), Prostate Cancer Treatment and Research (38 papers), Bladder and Urothelial Cancer Treatments (28 papers), Economic and Financial Impacts of Cancer (25 papers), Pancreatic and Hepatic Oncology Research (22 papers) and Radiopharmaceutical Chemistry and Applications (19 papers). The work is most often cited by research in Cancer Research (6.0k citations), Pulmonary and Respiratory Medicine (12.3k citations) and Oncology (6.1k citations). M. Dror Michaelson has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Robert J. Motzer, Thomas E. Hutson, Ronald M. Bukowski, Sindy T. Kim, Robert A. Figlin, Charles M. Baum, Piotr Tomczak, Sylvie Négrier, Stéphane Oudard and Isan Chen. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancer, British Journal of Cancer and The Oncologist.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.